Bath & Body Works Files Q2 2024 10-Q
Ticker: BBWI · Form: 10-Q · Filed: Aug 28, 2024 · CIK: 701985
| Field | Detail |
|---|---|
| Company | Bath & Body Works, INC. (BBWI) |
| Form Type | 10-Q |
| Filed Date | Aug 28, 2024 |
| Risk Level | medium |
| Pages | 17 |
| Reading Time | 20 min |
| Key Dollar Amounts | $0.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, earnings, retail
Related Tickers: BBWI
TL;DR
BBWI 10-Q filed: Q2 2024 financials out. Check for performance updates.
AI Summary
Bath & Body Works, Inc. filed its 10-Q for the period ending August 3, 2024. The filing details financial performance and operational updates for the second quarter of fiscal year 2024. Key financial figures and business segment information are presented, reflecting the company's ongoing strategies and market position.
Why It Matters
This filing provides investors with the latest financial results and operational details for Bath & Body Works, crucial for understanding the company's performance and future outlook.
Risk Assessment
Risk Level: medium — As a retail company, Bath & Body Works is subject to consumer spending trends, inventory management, and competitive pressures.
Key Players & Entities
- Bath & Body Works, Inc. (company) — Filer of the 10-Q
- L Brands, Inc. (company) — Former company name
- 20240803 (date) — End of reporting period
- 20240828 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended August 3, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on August 28, 2024.
What was Bath & Body Works, Inc.'s former company name?
Bath & Body Works, Inc. was formerly known as L Brands, Inc.
What is the Central Index Key (CIK) for Bath & Body Works, Inc.?
The Central Index Key (CIK) for Bath & Body Works, Inc. is 0000701985.
In which state was Bath & Body Works, Inc. incorporated?
Bath & Body Works, Inc. was incorporated in Delaware (DE).
Filing Stats: 4,990 words · 20 min read · ~17 pages · Grade level 14 · Accepted 2024-08-28 17:26:00
Key Financial Figures
- $0.50 — ange on which registered Common Stock, $0.50 Par Value BBWI The New York Stock Excha
Filing Documents
- bbwi-20240803.htm (10-Q) — 1078KB
- bbwi-202483_ex15.htm (EX-15) — 5KB
- bbwi-202483_ex22.htm (EX-22) — 5KB
- bbwi-202483_ex311.htm (EX-31.1) — 9KB
- bbwi-202483_ex312.htm (EX-31.2) — 9KB
- bbwi-202483_ex32.htm (EX-32) — 5KB
- 0000701985-24-000027.txt ( ) — 4750KB
- bbwi-20240803.xsd (EX-101.SCH) — 31KB
- bbwi-20240803_cal.xml (EX-101.CAL) — 49KB
- bbwi-20240803_def.xml (EX-101.DEF) — 116KB
- bbwi-20240803_lab.xml (EX-101.LAB) — 426KB
- bbwi-20240803_pre.xml (EX-101.PRE) — 292KB
- bbwi-20240803_htm.xml (XML) — 548KB
Financial Information
Part I. Financial Information
Financial Statements *
Item 1. Financial Statements * Consolidated Statements of Income (Unaudited) 3 Consolidated Statements of Comprehensive Income (Unaudited) 3 Consolidated Balance Sheets as of August 3 , 2024 (Unaudited), February 3, 2024 and July 29, 2023 (Unaudited) 4 Consolidated Statements of Total Equity (Deficit) (Unaudited) 5 Consolidated Statements of Cash Flows (Unaudited) 7
Notes to Consolidated Financial Statements (Unaudited)
Notes to Consolidated Financial Statements (Unaudited) 8 Report of Independent Registered Public Accounting Firm 15 Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 16
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 17
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 27
Controls and Procedures
Item 4. Controls and Procedures 28
Other Information
Part II. Other Information 29
Legal Proceedings
Item 1. Legal Proceedings 29
Risk Factors
Item 1A. Risk Factors 29
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 29
Defaults Upon Senior Securities
Item 3. Defaults Upon Senior Securities 29
Mine Safety Disclosures
Item 4. Mine Safety Disclosures 29
Other Information
Item 5. Other Information 29
Exhibits
Item 6. Exhibits 30 Signature 31 * The Company's fiscal year ends on the Saturday nearest to January 31. As used herein, "second quarter of 2024" and "second quarter of 2023" refer to the thirteen-week periods ended August 3, 2024 and July 29, 2023, respectively. "Year-to-date 2024" and "year-to-date 2023" refer to the twenty-six-week periods ended August 3, 2024 and July 29, 2023, respectively. 2 Table of Contents
—FINANCIAL INFORMATION
PART I—FINANCIAL INFORMATION
FINANCIAL STATEMENTS
Item 1. FINANCIAL STATEMENTS BATH & BODY WORKS, INC. CONSOLIDATED STATEMENTS OF INCOME (in millions, except per share amounts) (Unaudited) Second Quarter Year-to-Date 2024 2023 2024 2023 Net Sales $ 1,526 $ 1,559 $ 2,910 $ 2,955 Costs of Goods Sold, Buying and Occupancy ( 900 ) ( 937 ) ( 1,677 ) ( 1,737 ) Gross Profit 626 622 1,233 1,218 General, Administrative and Store Operating Expenses ( 443 ) ( 434 ) ( 863 ) ( 849 ) Operating Income 183 188 370 369 Interest Expense ( 77 ) ( 86 ) ( 159 ) ( 175 ) Other Income 47 25 61 45 Income Before Income Taxes 153 127 272 239 Provision for Income Taxes 1 28 33 59 Net Income $ 152 $ 99 $ 239 $ 180 Net Income per Basic Share $ 0.68 $ 0.43 $ 1.07 $ 0.79 Net Income per Diluted Share $ 0.68 $ 0.43 $ 1.06 $ 0.78 BATH & BODY WORKS, INC. CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (in millions) (Unaudited) Second Quarter Year-to-Date 2024 2023 2024 2023 Net Income $ 152 $ 99 $ 239 $ 180 Other Comprehensive Income (Loss), Net of Tax: Foreign Currency Translation ( 1 ) 2 ( 3 ) — Unrealized Gain (Loss) on Cash Flow Hedges 1 ( 1 ) 2 — Reclassification of Cash Flow Hedges to Earnings — ( 1 ) — ( 1 ) Total Other Comprehensive Income (Loss), Net of Tax — — ( 1 ) ( 1 ) Total Comprehensive Income $ 152 $ 99 $ 238 $ 179 The accompanying Notes are an integral part of these Consolidated Financial Statements. 3 Table of Contents BATH & BODY WORKS, INC. CONSOLIDATED BALANCE SHEETS (in millions, except par value amounts) August 3, 2024 February 3, 2024 July 29, 2023 (Unaudited) (Unaudited) ASSETS Current Assets: Cash and Cash Equivalents $ 514 $ 1,084 $ 790 Accounts Receivable, Net 146 224 153 Inventories 863 710 818 Other 143 97 132 Total Current Assets 1,666 2,115 1,893 Property and Equipment, Net 1,166 1,220 1,236 Operating Lease Assets 1,043 1,056 1,080 Goodwill 628 628 628 Trade Name 165 165 165 Deferred Income Taxes 143 144 38 Other Assets 137 135 155 Total Assets $ 4,948 $ 5,46
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) 1. Description of Business and Basis of Presentation Description of Business Bath & Body Works, Inc. (the "Company") is a global omnichannel retailer focused on personal care and home fragrance. The Company sells merchandise through its retail stores in the United States of America ("U.S.") and Canada, and through its websites and other channels, under the Bath & Body Works, White Barn and other brand names. The Company's international business is conducted through franchise, license and wholesale partners. The Company operates as and reports a single segment. Fiscal Year The Company's fiscal year ends on the Saturday nearest to January 31. As used herein, "second quarter of 2024" and "second quarter of 2023" refer to the thirteen-week periods ended August 3, 2024 and July 29, 2023, respectively. "Year-to-date 2024" and "year-to-date 2023" refer to the twenty-six-week periods ended August 3, 2024 and July 29, 2023, respectively. Basis of Consolidation The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. The Company accounts for investments in unconsolidated entities where it exercises significant influence, but does not have control, using the equity method. Under the equity method of accounting, the Company recognizes its share of the investee's net income or loss. Losses are only recognized to the extent the Company has positive carrying value related to the investee. Carrying values are only reduced below zero if the Company has an obligation to provide funding to the investee. The Company's share of net income or loss of all unconsolidated entities is included in Other Income in the Consolidated Statements of Income. The Company's equity method investments are required to be reviewed for impairment when it is determined there may be an other-than-temporary loss in